BRCA1 and ovarian cancer: Monogenic disease variants and PRS results are reported separately, without comment on any possible interaction between a monogenic result and a relevant PRS (for example, an average-risk BrCa PRS and a pathogenic variant in BRCA1 associated with hereditary breast and ovarian cancer).